Your browser doesn't support javascript.
loading
Greater dose-ranging effects on A1C levels than on glucosuria with LX4211, a dual inhibitor of SGLT1 and SGLT2, in patients with type 2 diabetes on metformin monotherapy.
Rosenstock, Julio; Cefalu, William T; Lapuerta, Pablo; Zambrowicz, Brian; Ogbaa, Ike; Banks, Phillip; Sands, Arthur.
Afiliação
  • Rosenstock J; Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX juliorosenstock@dallasdiabetes.com.
  • Cefalu WT; Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA.
  • Lapuerta P; Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
  • Zambrowicz B; Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
  • Ogbaa I; Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
  • Banks P; Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
  • Sands A; Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
Diabetes Care ; 38(3): 431-8, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25216510

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Glicosídeos / Hipoglicemiantes Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Care Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Glicosídeos / Hipoglicemiantes Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Care Ano de publicação: 2015 Tipo de documento: Article